Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Cato Mørk

66 publications found

Original articles

Christensen E, Mørk E, Foss OA, Mørk C, Kroon S, Dotterud LK, Helsing P, Vatne Ø, Skogvoll E, Mjønes P, Bachmann IM (2024)
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre study
PLoS One, 19 (3), e0299718
DOI 10.1371/journal.pone.0299718, PubMed 38457386

Brun MK, Gehin JE, Bjørlykke KH, Warren DJ, Klaasen RA, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Jahnsen J, Bolstad N, Jørgensen KK, Haavardsholm EA, Goll GL, Syversen SW (2024)
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Lancet Rheumatol, 6 (4), e226-e236
DOI 10.1016/S2665-9913(23)00341-7, PubMed 38402891

Brun MK, Bjørlykke KH, Viken MK, Stenvik GE, Klaasen RA, Gehin JE, Warren DJ, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Haavardsholm EA, Jahnsen J, Goll GL, Lie BA, Bolstad N, Jørgensen KK, Syversen SW (2023)
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
J Intern Med, 293 (5), 648-655
DOI 10.1111/joim.13616, PubMed 36843323

Brun MK, Goll GL, Jørgensen KK, Sexton J, Gehin JE, Sandanger Ø, Olsen IC, Klaasen RA, Warren DJ, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA, Syversen SW (2022)
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
J Intern Med, 292 (3), 477-491
DOI 10.1111/joim.13495, PubMed 35411981

Syversen SW, Jørgensen KK, Goll GL, Brun MK, Sandanger Ø, Bjørlykke KH, Sexton J, Olsen IC, Gehin JE, Warren DJ, Klaasen RA, Noraberg G, Bruun TJ, Dotterud CK, Ljoså MKA, Haugen AJ, Njålla RJ, Zettel C, Ystrøm CM, Bragnes YH, Skorpe S, Thune T, Seeberg KA, Michelsen B, Blomgren IM et al. (2021)
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 326 (23), 2375-2384
DOI 10.1001/jama.2021.21316, PubMed 34932077

Syversen SW, Goll GL, Jørgensen KK, Sandanger Ø, Sexton J, Olsen IC, Gehin JE, Warren DJ, Brun MK, Klaasen RA, Karlsen LN, Noraberg G, Zettel C, Ljoså MKA, Haugen AJ, Njålla RJ, Bruun TJ, Seeberg KA, Michelsen B, Strand EK, Skorpe S, Blomgren IM, Bragnes YH, Dotterud CK, Thune T et al. (2021)
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 325 (17), 1744-1754
DOI 10.1001/jama.2021.4172, PubMed 33944876

Syversen SW, Goll GL, Jørgensen KK, Olsen IC, Sandanger Ø, Gehin JE, Warren DJ, Sexton J, Mørk C, Jahnsen J, Kvien TK, Bolstad N, Haavardsholm EA (2020)
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Trials, 21 (1), 13
DOI 10.1186/s13063-019-3734-4, PubMed 31907007

Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G et al. (2019)
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
J Intern Med, 285 (6), 653-669
DOI 10.1111/joim.12880, PubMed 30762274

Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK, NOR-SWITCH study group (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Lancet, 389 (10086), 2304-2316
DOI 10.1016/S0140-6736(17)30068-5, PubMed 28502609

Namer B, Ørstavik K, Schmidt R, Kleggetveit IP, Weidner C, Mørk C, Kvernebo MS, Kvernebo K, Salter H, Carr TH, Segerdahl M, Quiding H, Waxman SG, Handwerker HO, Torebjörk HE, Jørum E, Schmelz M (2015)
Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
Pain, 156 (9), 1637-1646
DOI 10.1097/j.pain.0000000000000229, PubMed 25993546

Heppner HJ, Singler K, Sieber C, Christ M, Bahrmann P, Mork C (2014)
[Requirements for perioperative intensive care of geriatric patients]
Z Gerontol Geriatr, 47 (2), 125-30
DOI 10.1007/s00391-013-0597-2, PubMed 24619043

Bergersen TK, Hoffmann-Vold AM, Midtvedt Ø, Gran JT, Mørk C, Toska K, Elstad M (2014)
Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
PubMed 24847906

Seçkin D, Barete S, Euvrard S, Francès C, Kanitakis J, Geusau A, Del Marmol V, Harwood CA, Proby CM, Ali I, Güleç AT, Durukan E, Lebbé C, Alaibac M, Laffitte E, Cooper S, Bouwes Bavinck JN, Murphy GM, Ferrándiz C, Mørk C, Cetkovská P, Kempf W, Hofbauer GF (2013)
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series
Am J Transplant, 13 (8), 2146-53
DOI 10.1111/ajt.12281, PubMed 23718915

Ljosaa TM, Stubhaug A, Mork C, Moum T, Wahl AK (2013)
Improvement in Psoriasis Area and Severity Index score predicts improvement in skin pain over time in patients with psoriasis
Acta Derm Venereol, 93 (3), 330-4
DOI 10.2340/00015555-1456, PubMed 23007130

Christensen E, Mørk C, Skogvoll E (2012)
High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study
Br J Dermatol, 166 (6), 1342-8
DOI 10.1111/j.1365-2133.2012.10878.x, PubMed 22309486

Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Ibler KS, Jemec GB, Brocks KM, Philipsen PA, Heydenreich J, Hædersdal M, Wulf HC (2012)
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study
Br J Dermatol, 166 (6), 1327-32
DOI 10.1111/j.1365-2133.2012.10833.x, PubMed 22250644

Wiegell SR, Fabricius S, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Jemec GB, Mogensen M, Brocks KM, Philipsen PA, Heydenreich J, Haedersdal M, Wulf HC (2011)
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp
Br J Dermatol, 164 (5), 1083-90
DOI 10.1111/j.1365-2133.2011.10209.x, PubMed 21219287

Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK (2011)
Skin pain and skin discomfort is associated with quality of life in patients with psoriasis
J Eur Acad Dermatol Venereol, 26 (1), 29-35
DOI 10.1111/j.1468-3083.2011.04000.x, PubMed 21385220

Christensen E, Mørk C, Foss OA (2011)
Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy
J Skin Cancer, 2011, 240340
DOI 10.1155/2011/240340, PubMed 22191035

Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J (2010)
Influence of narrowband UVB phototherapy on vitamin D and folate status
Exp Dermatol, 19 (8), e67-72
DOI 10.1111/j.1600-0625.2009.00987.x, PubMed 19849714

Preus HR, Khanifam P, Kolltveit K, Mørk C, Gjermo P (2010)
Periodontitis in psoriasis patients: a blinded, case-controlled study
Acta Odontol Scand, 68 (3), 165-70
DOI 10.3109/00016350903583678, PubMed 20141361

Ljosaa TM, Rustoen T, Mörk C, Stubhaug A, Miaskowski C, Paul SM, Wahl AK (2010)
Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics
Acta Derm Venereol, 90 (1), 39-45
DOI 10.2340/00015555-0764, PubMed 20107724

Bergersen TK, Mørk C (2009)
[A 62-year-old woman with non-pitting leg oedema]
Tidsskr Nor Laegeforen, 129 (8), 750-2
DOI 10.4045/tidsskr.09.34625, PubMed 19373301

Wennberg AM, Stenquist B, Stockfleth E, Keohane S, Lear JT, Jemec G, Mork C, Christensen E, Kapp A, Solvsten H, Talme T, Berne B, Forschner T (2008)
Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study
Transplantation, 86 (3), 423-9
DOI 10.1097/TP.0b013e318180731e, PubMed 18698246

Krogstad AL, Mork C, Piechnik SK (2006)
Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis
Br J Dermatol, 154 (6), 1118-22
DOI 10.1111/j.1365-2133.2006.07212.x, PubMed 16704643

Wahl AK, Mørk C, Lillehol BM, Myrdal AM, Helland S, Hanestad BR, Moum T (2006)
Changes in quality of life in persons with eczema and psoriasis after treatment in departments of dermatology
Acta Derm Venereol, 86 (3), 198-201
DOI 10.2340/00015555-0062, PubMed 16710574

Walberg M, Mørk C, Sandven P, Jorde AT, Bjørås M, Gaustad P (2006)
18S rDNA polymerase chain reaction and sequencing in onychomycosis diagnostics
Acta Derm Venereol, 86 (3), 223-6
DOI 10.2340/00015555-0077, PubMed 16710579

Lear JT, Wennberg AM, Schmook T, Keohane S, Stenquist B, Jemec G, Mork C, Christensen E, Kapp A, Solvsten H, Talme T, Berne B, Stockfleth E (2006)
A multicenter, study of photodynamic therapy with methyl aminolevulinate (MAL-PDT) in immuno-compromised organ transplant recipients with non-melanoma skin cancer
EADV: PROCEEDINGS OF THE 15TH CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 677

Wahl AK, Mørk C, Hanestad BR, Helland S (2006)
Coping with exacerbation in psoriasis and eczema prior to admission in a dermatological ward
Eur J Dermatol, 16 (3), 271-5
PubMed 16709492

Davidsson S, Blomqvist K, Molin L, Mørk C, Sigurgeirsson B, Zachariae H, Zachariae R (2005)
Lifestyle of Nordic people with psoriasis
Int J Dermatol, 44 (5), 378-83
DOI 10.1111/j.1365-4632.2005.01925.x, PubMed 15869535

Wahl AK, Mørk C, Cooper BA, Padilla G (2005)
No long-term changes in psoriasis severity and quality of life following climate therapy
J Am Acad Dermatol, 52 (4), 699-701
DOI 10.1016/j.jaad.2005.01.117, PubMed 15793527

Ørstavik K, Mørk C, Kvernebo K, Jørum E (2004)
Pain in primary erythromelalgia--a neuropathic component?
Pain, 110 (3), 531-538
DOI 10.1016/j.pain.2004.03.030, PubMed 15288393

Mørk C, Salerud EG, Asker CL, Kvernebo K (2004)
The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study
J Invest Dermatol, 122 (3), 587-93
DOI 10.1111/j.0022-202X.2004.22339.x, PubMed 15086539

Mørk C, Ozek M, Wahl AK (2004)
[Psoriasis and psoriatic arthritis--is climate therapy a treatment or a leisure activity?]
Tidsskr Nor Laegeforen, 124 (1), 60-2
PubMed 14716397

Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2004)
Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers
J Eur Acad Dermatol Venereol, 18 (1), 27-36
DOI 10.1111/j.1468-3083.2004.00721.x, PubMed 14678528

Kalgaard OM, Mørk C, Kvernebo K (2003)
Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a double-blind randomized pilot study
Acta Derm Venereol, 83 (6), 442-4
DOI 10.1080/00015550310015031, PubMed 14690340

Mørk C, Kvernebo K, Asker CL, Salerud EG (2002)
Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism
J Invest Dermatol, 119 (4), 949-53
DOI 10.1046/j.1523-1747.2002.00218.x, PubMed 12406343

Mørk C, Wahl A (2002)
Improved quality of life among patients with psoriasis after supervised climate therapy at the Canary Islands
J Am Acad Dermatol, 47 (2), 314-6
DOI 10.1016/s0190-9622(02)00066-x, PubMed 12140483

Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2002)
Quality of life in 6497 Nordic patients with psoriasis
Br J Dermatol, 146 (6), 1006-16
DOI 10.1046/j.1365-2133.2002.04742.x, PubMed 12072069

Mørk C, Kalgaard OM, Kvernebo K (2002)
Impaired neurogenic control of skin perfusion in erythromelalgia
J Invest Dermatol, 118 (4), 699-703
DOI 10.1046/j.1523-1747.2002.01726.x, PubMed 11918719

Mørk C, Wahl A, Moum T (2002)
The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics
Acta Derm Venereol, 82 (5), 347-51
DOI 10.1080/000155502320624078, PubMed 12430733

Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2002)
Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study
Acta Derm Venereol, 82 (2), 108-13
DOI 10.1080/00015550252948130, PubMed 12125937

Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2001)
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study
Acta Derm Venereol, 81 (2), 116-21
DOI 10.1080/00015550152384254, PubMed 11501648

Mørk C, Kalgaard OM, Myrvang B, Kvernebo K (2000)
Erythromelalgia in a patient with AIDS
J Eur Acad Dermatol Venereol, 14 (6), 498-500
DOI 10.1046/j.1468-3083.2000.00145.x, PubMed 11444274

Moksnes A, Roskaft E, Hagen LG, Honza M, Mork C, Olsen PH (2000)
Common cuckoo Cuculus canorus and host behaviour at Reed Warbler Acrocephalus scirpaceus nests
Ibis, 142 (2), 247-258
DOI 10.1111/j.1474-919X.2000.tb04864.x

Mork C, Asker CL, Salerud EG, Kvernebo K (2000)
Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia
J Invest Dermatol, 114 (4), 643-6
DOI 10.1046/j.1523-1747.2000.00944.x, PubMed 10733667

Strømme P, Sundet K, Mørk C, Cassiman JJ, Fryns JP, Claes S (1999)
X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11
J Med Genet, 36 (5), 374-8
PubMed 10353782

Mørk C (1999)
[Who shall be treated for excessive sweating and how?]
Tidsskr Nor Laegeforen, 119 (2), 178
PubMed 10081345

Mörk C (1992)
[Here is New Ventures!]
Vardfacket, 16 (17), 4
PubMed 1300843

Mørk C, Gabrielsen TO (1991)
[Cowden's disease. A syndrome with multiple hamartomas and neoplasias]
Tidsskr Nor Laegeforen, 111 (19), 2432-4
PubMed 1926083

Braathen LR, Ramirez G, Kunze RO, Mork C, Strand O (1991)
Latent infection of epidermal Langerhans cells in HIV-positive individuals
Res Virol, 142 (2-3), 119-21
DOI 10.1016/0923-2516(91)90047-7, PubMed 1896635

Mörk C (1990)
[Focus on work environment. The soul fares ill when the work environment is poor]
Vardfacket, 14 (20), 24
PubMed 2096545

Mørk C, van Deurs B, Petersen OW (1990)
Regulation of vimentin expression in cultured human mammary epithelial cells
Differentiation, 43 (2), 146-56
DOI 10.1111/j.1432-0436.1990.tb00441.x, PubMed 2373288

Jensen P, Leite K, Lützow-Holm C, Mørk C, Steinkjer B, Søyland E (1988)
[Consultation analysis in hospitals. Experiences of an educational program in communication with patients]
Tidsskr Nor Laegeforen, 108 (32), 2957-8
PubMed 3252539

Mørk C, Braathen LR (1988)
[Minoxidil--a hope for patients with androgen alopecia?]
Tidsskr Nor Laegeforen, 108 (28), 2391-3
PubMed 3061060

Mørk C, Braathen LR (1988)
[Androgenic alopecia]
Tidsskr Nor Laegeforen, 108 (28), 2388-90
PubMed 3206449

Holmertz V, Mörk C, Stubbendorff S, Thomasson J, Trozell M (1987)
[Dialysis accidents--4 years after. Who takes responsibility when safety is lacking? Worried members interrupt work]
Vardfacket, 11 (22), 4-6
PubMed 3442122

Mørk C, Braathen LR (1987)
[Iontophoresis in the treatment of hyperhidrosis]
Tidsskr Nor Laegeforen, 107 (16), 1468-9
PubMed 3603515

Review articles

Ingvaldsen CA, Leegaard TM, Kravdal G, Mørk C (2020)
Infectious Pseudochromhidrosis: A Case Report and Literature Review
Acta Derm Venereol, 100 (1), adv00005
DOI 10.2340/00015555-3338, PubMed 31612235

Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, Stang HJ, Vatne O, Mørk C, Norwegian Photodynamic Therapy (PDT) Group (2009)
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer
J Eur Acad Dermatol Venereol, 24 (5), 505-12
DOI 10.1111/j.1468-3083.2009.03430.x, PubMed 19807828

Mørk C (1997)
[Hair loss. Causes, diagnosis, clinical manifestations and treatment]
Tidsskr Nor Laegeforen, 117 (21), 3103-6
PubMed 9381446